指南与共识消化道肿瘤放疗放疗物理与技术

胰腺癌放射治疗:ASTRO临床实践指南执行摘要

Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline.
指南 / 共识 · Pract Radiat Oncol · 2019-01-01

美国放射肿瘤学会(ASTRO)组建工作组,围绕7个关键问题系统综述证据,形成胰腺癌放疗指南。指南有条件推荐特定患者新辅助和根治性放疗可用常规分割或立体定向体部放疗,辅助治疗用常规分割方案,并推荐调强技术、运动管理、每日影像引导及预防性止吐等措施。

要点

  • 特定患者新辅助和根治性放疗可有条件推荐常规分割或立体定向体部放疗。
  • 辅助治疗有条件推荐常规分割方案。
  • 推荐运动管理、每日影像引导、使用对比剂和调强技术。

核心结论

  • 胰腺癌放疗作用正在演变,随着新型全身治疗发展和局部控制受重视,放疗可能更为重要。
  • 应与患者及家属讨论现有数据的细微差别,并以多学科方式协调诊疗。

研究设计与样本

  • 美国放射肿瘤学会(ASTRO)组建工作组,基于系统文献综述和预设共识构建方法及证据质量与推荐强度分级系统制定指南。
  • 工作组围绕放疗的7个关键问题,包括剂量分割与治疗体积、模拟与治疗计划、放疗相关毒性预防。

主要发现

  • 指南有条件推荐特定患者的新辅助和根治性治疗可采用常规分割或立体定向体部放疗。
  • 指南有条件推荐辅助治疗采用常规分割方案。
  • 工作组提出适宜的剂量分割方案范围,并就靶区体积及放疗与化疗的顺序提供推荐。
  • 推荐运动管理、每日影像引导、使用对比剂和调强技术治疗。
  • 工作组支持预防性止吐药物,患者也可能从减少胃酸分泌的药物中获益。

关键数值与推荐

  • 新辅助和根治性治疗:特定患者有条件推荐常规分割或立体定向体部放疗。
  • 辅助治疗:有条件推荐常规分割方案。

临床怎么用

  • 根据患者治疗场景(新辅助、根治性、辅助)选择指南有条件推荐的相应剂量分割方案。
  • 实施运动管理、每日影像引导、使用对比剂和调强技术。
  • 考虑预防性止吐药物,并评估减少胃酸分泌药物的获益。
  • 与患者及家属讨论现有数据的细微差别,并以多学科方式协调诊疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This guideline systematically reviews the evidence for treatment of pancreatic cancer with radiation in the adjuvant, neoadjuvant, definitive, and palliative settings and provides recommendations on indications and technical considerations. METHODS AND MATERIALS: The American Society for Radiation Oncology convened a task force to address 7 key questions focused on radiation therapy, including dose fractionation and treatment volumes, simulation and treatment planning, and prevention of radiation-associated toxicities. Recommendations were based on a systematic literature review and created using a predefined consensus-building methodology and system for grading evidence quality and recommendation strength. RESULTS: The guideline conditionally recommends conventionally fractionated or stereotactic body radiation for neoadjuvant and definitive therapy in certain patients and conventionally fractionated regimens for adjuvant therapy. The task force suggests a range of appropriate dose-fractionation schemes and provides recommendations on target volumes and sequencing of radiation and chemotherapy. Motion management, daily image guidance, use of contrast, and treatment with modulated techniques are all recommended. The task force supported prophylactic antiemetic medication, and patients may also benefit from medications to reduce acid secretion. CONCLUSIONS: The role of radiation in the management of pancreatic cancer is evolving, with many ongoing areas of active investigation. Radiation therapy is likely to become even more important as new systemic therapies are developed and there is increased focus on controlling local disease. It is important that the nuances of available data are discussed with patients and families and that care be coordinated in a multidisciplinary fashion.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Palta M, Godfrey D, Goodman KA, et al. Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2019. PMID: 31474330. doi:10.1016/j.prro.2019.06.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。